Point of View: Medicare Profitability in a Reform Market

Similar documents
MEDICARE ADVANTAGE MA Plans. to $28 per month 46% HOW HEALTH SYSTEMS CAN THRIVE WITH. Developing Your Medicare Advantage Strategy PRODUCT

partnering with payers? key lessons to keep in mind

The Emergence of Value-Based Care: Present and Future Tense

The Case For Value ACA to MACRA to MIPS

First a word about the rising cost of retiree healthcare

Medicare payment policy and its impact on program spending

TRACKING MEDICARE HEALTH AND PRESCRIPTION DRUG PLANS Monthly Report for April 2007

Volume to Value The Great Transformation of American Medicine

Healthcare Reform and Its Impact on the Care Delivery System

Narrow, Tailored, Tiered and High Performance Networks: An Emerging Trend

Assessing ACO Performance

Session 115IF, Provider Risk-Sharing Arrangements in Medicaid. Presenters: Puneet Budhiraja, ASA, MAAA Michael Minor Sudha Shenoy, FSA, MAAA, CERA

National Conference of State Legislatures

Changes to Medicare under the Affordable Care Act

Gulf Coast and LA HFMA Payer Summit Value-based contracts same healthcare business?

Prospective vs. Retrospective. Will Bundled Payment Really Be.. Fee For Service

Part One: FEDERAL POLICY AND MEDICARE S IMPACT ON THE ECONOMY

March 28, Dear Administrator Slavitt:

San Francisco Health Service System Health Service Board

Reinsurance Section News

How Bundled Payments Create Value in New Product Designs Cognizant

The 2018 Advance Notice and Draft Call Letter for Medicare Advantage

HEALTH CARE COSTS ARE THE PRIMARY DRIVER OF THE DEBT

A Practical Discussion of Value and Quality Based Payments What Do I Do Now?

The Medicare Advantage program: Status report

FMV Considerations for Bundled Payment Arrangements

Figure 1: Original APM Framework

Developing Your Value Proposition. Timothy P. McNeill, RN, MPH

Why Medicare Advantage Is Marching Toward 70% Penetration

04/12/2016 C H A L L E N G E S F A C I N G U N I T E D S T A T E S H E A L T H C A R E S Y S T E M

JOINT TASK FORCE ON HEALTH CARE COST REVIEW (Senate Bill 419)

CF Health Advisors: Partner Biographies

HEALTH POLICY & EDUCATION SERIES

TRACKING MEDICARE HEALTH AND PRESCRIPTION DRUG PLANS Monthly Report for August 2007

Medicare Advantage: 2016 National Snapshot

Why a Successful Population Health Strategy Must Include Medicare Advantage

CMS 1701 P UnityPoint Health. October 16, 2018

Medicare Advantage: Program Overview and Recent Experience. James Cosgrove, Ph.D. Director, Health Care U.S. Government Accountability Office

Medicare Advantage: 2015 National Snapshot

CURRENT DEVELOPMENTS IN VALUE BASED PAYMENT (VBP): Part 1 Recent Initiatives

HEALTH CARE COSTS ARE THE PRIMARY DRIVER OF THE DEBT

Utilizing Predictive Models to Target for Clinical and Diagnosis Gaps. Predictive Modeling Summit September 16, 2016 Presented by Scott Weiner

An Introduction to Value Based Care. Evan Richards Product Leader Value Based Care Solutions May 2016

Vertical Integration Trends and Impacts: (a) Physicians & Hospitals (b) Payers & Providers

Strategic Purchasing of Medical Devices

What s Next for MSSP ACOs? The Case for Moving to Medicare Risk

Lessons Learned, What s Next

MACRAnomics. Patient-Level Economics and Strategic Implications for Providers. Presented to: NW Ohio HFMA October 20, 2016

MACRA: APPLICATIONS & IMPLICATIONS September 13, /13/2016. Mark Blessing, CPA, FHFMA Partner

Medicare Overview Employer Options and Trends

Provisions of the Medicare Modernization Act

What Every Actuary Should Know About Medicare From Structure to Reform

TRACKING MEDICARE HEALTH AND PRESCRIPTION DRUG PLANS Monthly Report for March 2007

Session 75 OF, Advantages & Challenges for Provider Led Health Plans. Moderator: LuCretia Leola Hydell, ASA, MAAA

Medicare at 50. R. B. Drennan, PhD Associate Professor Fox School of Business Temple University 28 January 2016

Providers involved in the Centers for Medicare & Medicaid Services ACE demonstration project share

The ACO Track One+ Model: New Rewards for Risk

TRACKING MEDICARE HEALTH AND PRESCRIPTION DRUG PLANS Monthly Report for February 2008

FINANCING AND PAYMENT ISSUES IN RURAL LONG TERM CARE INTEGRATION

Affordable Care Act Update: Implementing Medicare Costs Savings

WHO BENEFITS FROM MEDICARE ADVANTAGE?

March 4, Dear Mr. Cavanaugh and Ms. Lazio:

TRACKING MEDICARE HEALTH AND PRESCRIPTION DRUG PLANS Monthly Report for September 2007

Medicare Accountable Care Organizations What & Why?

Better Medicare Alliance Webinar: Medicare Advantage and Part D 2019 Advance Notice and Draft Call Letter. February 8, 2018

Centers for Medicare & Medicaid Services: Innovation Center New Direction Request For Information: Medicare Advantage (MA) Innovation Models

THE FAST AND THE FURIOUS REVENUE CYCLE (A.K.A.) THE REVENUE CYCLE OF THE FUTURE

MEDICARE ADVANTAGE IN RURAL AREAS: EXPERIENCE UNDER THE MMA

TRACKING MEDICARE HEALTH AND PRESCRIPTION DRUG PLANS Monthly Report for October 2007

The Payment Reform GLOSSARY. Definitions and Explanations of the Terminology Used to Describe Methods of Paying for Healthcare Services.

FORM 6-K. FRESENIUS MEDICAL CARE AG & Co. KGaA (Translation of registrant s name into English)

Configuration of Network and Financial Management Systems to Support Multiple Value Based Reimbursement Models

Medicare Advantage Value-Based Insurance Design: Considerations and implications

Collaborative Health Systems a Universal American company. CHS and ACO Overview May 2016

An Examination of Medicare Private Fee-for-Service Plans

AFFORDABILITY REVIEW. Mysteries of the Medical Loss Ratio

Population-Based Healthcare: Structural Models and Options

Medicare Advantage (MA) Proposed Benchmark Update and Other Adjustments for CY2020: In Brief

How Health Reform Saves Consumers and Taxpayers Money

Risk Contracting: What to Know About Stop Loss Insurance KATHRYN A BOWEN, EXECUTIVE VICE-PRESIDENT OCTOBER 27, 2016

Summary of Medicare Provisions in the President s Budget for Fiscal Year 2016

Medicare: Changes, Challenges, and Opportunities for Grantmakers

SNF Market Trends. Understanding the Changes Impacting Our Business. Trend 1: Medicaid Managed Care

S E C T I O N. National health care and Medicare spending

M E D I C A R E I S S U E B R I E F

Connecting Risk, Severity, and Quality in Healthcare Measurement and Management. American College of Medical Quality October 29, 2009

Evidence-Based Program Reimbursement Strategies. Timothy P. McNeill, RN, MPH

New Opportunities, With ACA & QHI Support

Alternative Payment Models and Clearinghouses Education and Impacts. White Paper by the Emerging Trends and Strategic Innovation Committee

than value. infrastructure for value-based payment, it is apparent that greater assumption of

Provider Reimbursement Strategies & Opportunities Board of Trustees Meeting

Clinically Integrated Networks and Population Health The next chapter in healthcare

CNYCC Joint Board and Finance Committee Forum

The Health Insurance Market in Virginia. Maureen Dempsey, MD, MSc, ACC, FAAP Anthem Blue Cross and Blue Shield June 8, 2017

Advancing Risk Capability in 2015: Medicare Shared Savings Program and ACO Investment Model. March 23, 2015 // 12:00 P.M. 1:00 P.M.

Innovation in Health Care Delivery and Benefits

White Paper. AMGA Advocacy. Taking Risk, 3.0: Medical Groups Are Moving to Risk Is Anyone Else? AMGA s Third Annual Survey on Taking Risk

2016 ADVANCE NOTICE: CHANGES TO MEDICARE ADVANTAGE PAYMENT METHODOLOGY AND THE POTENTIAL EFFECT ON MEDICARE ADVANTAGE ORGANIZATIONS AND BENEFICIARIES

Healthcare Executive MAY/JUNE 2015

Medicare Advantage and Part D Reform under the Patient Protection and Affordable Care Act (PPACA)

Transcription:

Point of View: Profitability in a Reform Market Bill Eggbeer, Managing Director, & Krista Bowers, Director, BDC Advisors, LLC Introduction Overall, accounts for approximately 20% of the total domestic healthcare spending, but is often 50% or more of a hospital s total reimbursement. The average annual total budget will grow by 6% annually between 2013 to 2020 according to the most recent National Health Expenditure Projections. This annual increase reflects increasing costs per member and the increased enrollment expected due to baby boomers approximately 12 million new enrollees will become eligible for coverage during this time. will continue to increase in importance as a payer for hospitals and physicians. While grows in importance, commercial revenues will be growing more slowly, or shrinking, as small group and individually insured patients move into Health Insurance Exchanges, with lower reimbursement rates, and as employers put pressure on payers to drive down large group insurance costs. Hospitals ability to cover losses with commercial profits is diminishing, forcing a rethinking of as a business segment, with new focus on profitability. Shifting Landscape As illustrated in Figure 1, below, is an increasingly complex market segment, with ongoing Figure 1: Business Case Market The medicare market is becoming complex and experiencing downward margin pressure... Today tomorrow Traditional FFS DRGs with Outlier Adjustments Advantage FFS DRGs Aco Shared Savings Traditional FFS DRGs with Value-Based Purchasing Adjustments Dual Eligible Special Needs Advantage Risk-Based Advantage FFS DRGs 1 National Health Insurance Projections 2011-2021, Centers for & Medicaid Services Boston Chicago Houston Los Angeles Miami San Francisco Washington, DC 1

changes to the traditional fee-forservice business model, widespread participation in the Shared Savings Program (ACO) pilot, bundled pricing initiatives, and rapid growth in private Advantage and Dual Eligible plans. In traditional, a host of CMS initiatives, with both carrots and sticks, are aimed at reducing the rate of growth in medical costs, with particular focus on the hospital. The Hospital Value-Based Purchasing Program, makes incentive payments to hospitals based on their performance against certain quality metrics and punishes hospitals for utilization attributed to hospital acquired infections. The Hospital Readmissions Reduction Program forces hospitals to absorb the costs of excessive readmissions. The net effect, for most hospitals, will be reduced, or more slowly growing, revenue per admission. The Shared Savings Programs (ACO and Pioneer ACO) and the state -Medicaid Dual Eligible pilots will likely have an increasing impact on the marketplace and favor organizations with care and risk management capabilities: approximately 4 million beneficiaries will be covered in these demonstration programs in 2014, but the impact will be broader, with a positive spillover of clinical efficiencies to other insured populations. The Bundled Payment for Care Initiatives Program announced January 31, 2013, will involve some 450 different hospitals across the nation in a 3 year program who will set payments for 48 different episodes of care. Advantage is rapidly increasing in importance as a sub segment of the market. Enrollment in Advantage is up 30% since 2010 and 10% between 2012 and 2013. In 2013, enrollment will be over 14 million beneficiaries, which is 28 percent of the population, up from 24% just 4 years ago. In some markets, Advantage penetration is reaching 45-50%. Strategic Options Improving profitability requires a strategy that balances operational improvements to optimize reimbursement under the traditional fee-for-service program, moving to risk to capture the value inherent in more effective medical management, and expanding market share to achieve economies of scale. Four strategies have emerged as key plays for leading health systems: Option #1: Reduce Costs and Move towards Break Even on FFS. Traditional feefor-service reimbursement is not going away, but is definitely in the cross-hairs of policy makers. Most Boston Chicago Houston Los Angeles Miami San Francisco Washington, DC 2

providers will continue to be paid FFS/DRG rates for major portions of their business. Succeeding in this pressurized reimbursement environment will require relentless emphasis on the reduction of unit costs through improved clinical efficiency, increased throughput and reduction of length of stay, and improved care management for episodes of care, chronic disease and end-of-life care. A significant degree of clinical integration and effective care management capabilities will be required to achieve these efficiencies, with hospitals and physicians aligned to manage care and eventually share risk. Option #2: Participate in the ACO / Shared Savings Program. Provider organizations and health systems participating in ACOs have the prospect of earning a portion of the savings they generate in addition to their normal and FFS reimbursement. The Shared Savings model is potentially superior to FFS as it provides an opportunity to gain valuable population management skills, with some upside revenue opportunity to offset revenue declines resulting from reduced utilization. ACOs are a good option for large medical groups who are accustomed to risk arrangements and who have a strong primary care base. Approximately 250 organizations have now been approved for the Shared Savings program serving an estimated 4 million beneficiaries. However, there are risks to participating in the program since a significant infrastructure investment is required; there is a 2-3.0% threshold to share any savings and a short half-life for shared savings opportunities, since the bar is likely to be continually reset in terms of performance. (Any savings between 0 and 2%, of course, is kept by CMS.) In addition, scale is important, and at least 5,000 enrollees may be needed to meet Minimum Saving Rate thresholds. In addition, ACOs require significant clinical informatics and care management infrastructure. Moreover, the Shared Savings program provides little or no control of the major managed care levers such as product design, member incentives, pre-authorization, or utilization control. For physician groups and health systems with effective care management capabilities, however, ACO shared savings participation is clearly preferable to riding the deteriorating traditional fee-forservice model with sub-inflation rate reimbursement increases. Option #3: Develop a Plan for Bundled Payments. Under the Boston Chicago Houston Los Angeles Miami San Francisco Washington, DC 3

Bundled Payment Care Initiative Program announced in January, 450 different provider organizations have entered into payment arrangements that will include financial and performance accountability for 48 different episodes of care. The BPCI program is comprised of (i) one model covering retrospective bundled payment for Acute Care Hospital Stay only; (ii) one model combining retrospective payment for Acute Care Hospital Stay and Post- Acute Care; (iii) a model providing retrospective payment for Post-Acute Care only; and (iv) a model providing prospective bundled payment for Acute Care Hospital Stay only. This is an ongoing program, however, and CMS has largely closed out the application process given the strong response. Option #4: Start to Accept Risk for Advantage. Developing a strategy to accept risk for Advantage may be the most attractive option for improving profitability. A wide range of risk options are available, ranging from fee-for-service contracts with performance incentives, to ownership of Advantage plans, as illustrated in Figure #2, below. Figure #2 - Advantage Risk Consideration Continuum Contract with Health Plan Partner with Health Plan Go It Alone Fee-for- Service Contract PHP Contract Shared Savings Contract Full Cap/ Global Budget Contract Private- Label Product Partnership Provider Sponsored Health Plan Provider Sponsored Health Plan Outsourced Services Lower Risk/Reward Tradeoffs Higher Selecting an option should be influenced by capabilities and risk appetite, but rewards increase substantially as providers move upstream. Boston Chicago Houston Los Angeles Miami San Francisco Washington, DC 4

Focus on Advantage - Debunking Myths: Despite the fact that MA accounts for almost 30% of the market, it has been, until recently, under the radar for most healthcare systems. Most hospitals contract with Advantage plans on a straight fee-forservice basis at rates that largely mirror those of traditional. We believe participation on a risk-basis in Advantage has been viewed unfavorably by many health system leaders as a result of three myths: Myth #1: Advantage is Unstable & Going Away Fact: PPACA killed a sub segment of the Advantage program, Private Fee-for-Service Plans, that has long been a target of policy makers. The heart of the Advantage program, HMO, PPO, and Special Needs Plans, has strong support among many policy makers and, as discussed above, a rapidly growing consumer constituency. Earlier this year, there was a great deal of attention and focus on the 2014 Advantage rates, with the legitimate concern that CMS actuarial calculations for the national annual per capita growth rate for would result in a (22%) reduction in Advantage rates, which would seriously destabilize the program. These proposed rates generated a massive industry lobbying effort and, coupled with Congressional concern, resulted in CMS correcting what is informally known as the the Doc Fix, the SGR issue that had been lingering since the 1997 BBA, which averted the severe year-over-year reduction, but did not specifically address the annual per capita growth rate issue. Most important, however, is the fact that both industry associations and Congress were able to affect a positive reimbursement change that will support the ongoing viability of the Advantage program. Figure #3 Advantage Plan Profitability Advantage Plan Profitability by Year Year % of Total Plans Profitable % of Plans >5,000 Members Profitable 2008 61.4% 71.8% 2009 70.5% 79.4% 2010 66.5% 74.4% Source: Mark Farrah Associates; NAIC Data-File Operation by Lines of Business Information; BDC Advisors Analysis Boston Chicago Houston Los Angeles Miami San Francisco Washington, DC 5

Myth #2: A Large MA Population is Required to Spread Risk Fact: Because of their higher utilization than commercial plans, MA plans can be viable at 5,000 to 10,000 members; 20,000 to 30,000 member plans can be very profitable. Figure #3 shows the total number of Advantage plans that were profitable by a membership breakdown at above and below 5,000 members for 2008 through 2010, for which data is available. In 2010, just under 75% of plans over 5,000 lives were profitable. Myth #3: Participation in a Advantage Plan is Highly Risky Fact: Retrospective risk adjustment makes Advantage plans much less risky than a typical commercial plan. Advantage plans conduct health risk assessments on members and submit risk scores to CMS. Premium levels are adjusted based on health risk, so plans have little underwriting risk related to adverse selection. Key Success Factors Many of the key functions for a successful Advantage Plan, in fact, are similar to those required of an Accountable Care Organization, including: (i) physician alignment and care / population management; (ii) network contracting and management; (iii) CMS reporting & compliance; and (iv) member communication. Other functions such as plan management, marketing, member operations, and actuarial pricing & bid capabilities, are services which could be purchased from a health plan partner or a Third Party Administrator. Succeeding in Advantage requires mastery of four essential capabilities: Product Design to ensure balance between competitive attractiveness and adverse risk selection. Revenue Management to optimize risk, ensure coding is accurate, and capture, as well as achieve, 4 or 5 STAR ratings for quality. Without a top STAR quality rating, an MA provider will not have a competitive product. Care Management with particular focus on management of chronic disease in the frail, elderly, and endof-life care. Regulatory Compliance with focus on management of all aspects of the value chain based on CMS rules. Provider-Sponsored Advantage Plans Outperform Traditional Plans Provider owned plans have traditionally out-performed national and regional plans in key areas of success including revenue management and STAR ratings; currently, all of the 4 or 5 2 Examples of 4 or 5 STAR plans: Kaiser, UPMS For Life, Giesinger Gold, Baystate Health, Group Health Cooperative, AdvoCare, Gunderson Lutheran. Most national and regional players such as United, Aetna, WellPoint, Humana or the Blues affiliates are 3 to 4 STAR. Boston Chicago Houston Los Angeles Miami San Francisco Washington, DC 6

STAR MA plans nationally are provider owned. 2 Provider-Sponsored MA plans have been able to better manage total cost of care, and their Medical Loss Ratios normally run below commercial, open access Advantage Health Plans. Finally, health plan members are first and foremost patients whose most important relationship with the healthcare system is their physician. Provider-Sponsored health plans have an opportunity to leverage the unique relationship between network physicians and patients/members. Evaluating the Advantage Opportunity CMS contracts with Advantage plans on a county-specific basis, and premiums vary widely by county based on a complex set of factors. The first step in the analysis of a Advantage opportunity is a basic financial feasibility assessment for the counties of interest, testing a set of underlying market conditions, including these factors: Market Size Projected Population Growth Advantage Enrollment and Penetration Rates Analysis approach Market Size Market Growth Product Mix Advantage Plan Market Share Group vs Individual MA Attractiveness County Pro Formas Partnership RFI Analysis-Potential Opportunities to Move Along Value-Based Corridor Impact ACA Network Strength Competitive Reaction Value-Based Contracting Boston Chicago Houston Los Angeles Miami San Francisco Washington, DC 7

FFS Benchmark County Level Revenue FFS County Level FFS Costs Risk Score for the County Population The output from the feasibility assessment will show how financially attractive Advantage is in targeted markets. The next step is a more detailed pro forma development process, taking into account product design and an actuarially based analysis of revenues and costs. The result is a three to five year pro forma that, coupled with a detailed market analysis and internal capabilities assessment, can inform a decision to enter a risk arrangement with an existing plan, or start a new provider-sponsored plan. This process will include an assessment of partnerships with an existing health plan, either informally, or through a formal Request for Information (RFI) or Request for Proposal (RFP) process. The process concludes with a definition of market entry options and evaluation of start-up costs. for all provider organizations and health systems. Starting with a basic financial feasibility assessment is the first step in the process and can help guide organizations toward defining how best to leverage the population management skills and value-based contracting efforts that are going to be required for long-term financial success. For more information, contact: Bill Eggbeer Managing Director 410-544-7402 bill.eggbeer@bdcadvisors.com Krista Bowers Director 818-219-7755 krista.bowers@bdcadvisors.com conclusion Advantage can be a key strategy for achieving profitability in the new world of Health Care Reform and the growth likely to come from the Baby Boomers. Deciding how best to consider taking on risk is the key strategic decision Boston Chicago Houston Los Angeles Miami San Francisco Washington, DC 8